Sort
82,697 grants matching “vaccine development”
Natural History of Pre-diabetic Autoimmunity (DAISY)
$810,548Marian J. Rewers · University Of Colorado Denver · R37 · FY2010 · DK
Clonal Dynamics of HIV/SIV-specific T cells
$810,532Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,532Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,531Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,531Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$810,531Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children
$810,525Lisa M Bebell · Massachusetts General Hospital · R01 · FY2023 · HD
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA VACCINE RESEARCH
$810,458John Jay Treanor · University Of Rochester · N01 · FY2020 · AI
SARS-CoV-2 correlates of protection in a Latino-origin population
$810,388Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2022 · CA
Biomolecule Production
$810,352Robin A Ross · Harvard Medical School · U54 · FY2012 · AI
Immune engineering of optimized sequential immunization strategies for HIV vaccines
$810,280Darrell J Irvine · Massachusetts Institute Of Technology · R33 · FY2024 · AI
Human Monoclonal Antibodies for Encephalitic Alphaviruses
$810,278James E Crowe · Vanderbilt University Medical Center · R01 · FY2023 · AI
Assembly of MHC Class I Molecules in Vitro and in Vivo
$810,147Hidde L Ploegh · Whitehead Institute For Biomedical Res · R01 · FY2012 · AI
Allogeneic glioma vaccine using TGF-beta knockouts
$810,121Habib Fakhrai · Novarx Corporation · R44 · FY2007 · CA
A Comprehensive Pre-Natal Intervention to Increase Vaccine Coverage
$810,107Saad B. Omer · Emory University · R01 · FY2018 · AI
Task V24: Cell line optimization and pre-master bank generation for a Hepatitis B Virus (HBV) vaccine
$810,077Thomas Hassel · International Aids Vaccine Initiative · N01 · FY2020 · AI
Effects of obesity on the dynamics of Influenza transmission
$810,075Stacey L Schultz-Cherry · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence
$810,013Robert D. Burk · Albert Einstein College Of Medicine · R01 · FY2025 · DE
How antigen exposure shapes the subsequent NK cell response to HIV
$810,003Silke Paust · Jackson Laboratory · R01 · FY2024 · AI
Development of Robust and Low-cost Vaccines Against Salmonella Paratyphi A
$810,000Rocio Canals Alvarez · Glaxosmithkline Biologicals · R01 · FY2023 · AI
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance
$810,000Anthony Bernard Schryvers · University Of Calgary · R01 · FY2021 · AI
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance
$810,000Anthony Bernard Schryvers · University Of Calgary · R01 · FY2020 · AI
Center: IUCRC Phase III University of Arkansas: Center for Membrane Applications, Science and Technology (MAST)
$809,992Sumith R Wickramasinghe · University Of Arkansas · · FY2024 · ENG
Host Genetic Determinants of HIV Pathogenesis
$809,958Sunil K Ahuja · University Of Texas Hlth Science Center · R37 · FY2007 · AI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$809,949Chetan Seshadri · University Of Washington · R01 · FY2023 · AI